Loading...
•
Aug 25, 2024
Lifecore Biomedical Q1 2025 Earnings Report
Lifecore Biomedical reported financial results for the first quarter of fiscal 2025.
Key Takeaways
Lifecore Biomedical reported a revenue increase of $0.2 million compared to the same period last year, driven by HA manufacturing revenues, but experienced a net loss of $16.2 million, which is higher than the net loss of $10.8 million in the comparable period of 2023. The company signed four new customers and multiple expansion agreements and successfully closed a $24.3 million private placement. They also reaffirmed their fiscal year 2025 revenue guidance of $126.5 to $130 million and Adjusted EBITDA guidance of $19 to $21 million.
Revenues for the quarter ended August 25, 2024, were $24.7 million, compared to $24.5 million for the comparable 2023 period.
Signed four new customers and multiple expansion agreements for existing customer projects.
Successfully closed a $24.3 million private placement, providing financial runway for current liquidity needs and future growth.
Reaffirmed fiscal year 2025 revenue guidance of $126.5 to $130 million and Adjusted EBITDA guidance of $19 to $21 million.
Forward Guidance
For the full fiscal year 2025, the company is reiterating its financial guidance and expects revenue to be approximately $126.5 to $130 million and Adjusted EBITDA to be in the range of $19 to $21 million.
Positive Outlook
- Revenue to be approximately $126.5 to $130 million.
- Adjusted EBITDA to be in the range of $19 to $21 million.
- Guidance considers existing market forces.
- Guidance considers contracts.
- Guidance considers timing of customer orders.
Challenges Ahead
- New business development organization usually takes multiple quarters to optimize performance.
- Company cautions against extrapolating quarterly results to estimate full year results.
- Financial guidance involves estimations with respect to success and timing related to growing and diversifying the company’s new business development revenue.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...